Business Wire

EUMETSAT: Europe’s First Geostationary Sounder Satellite Is Launched

2.7.2025 13:20:00 CEST | Business Wire | Press release

Share

Europe has taken a major step forward in strengthening its resilience to extreme weather events with the successful launch of the Meteosat Third Generation Sounder 1 (MTG-S1) satellite. MTG-S1 will deliver new streams of atmospheric data, enabling earlier, more accurate warnings that protect lives, property and infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702002782/en/

MTG-S1 is part of the Meteosat Third Generation programme, Europe’s new fleet of geostationary meteorological satellites. Image: EUMETSAT

Extreme weather events like storms, flooding, and heatwaves have caused hundreds of billions of euros in damage and claimed tens of thousands of lives across Europe in the past decades. Launched on 1 July 2025, MTG-S1 will provide Europe’s national meteorological services with high-frequency data on temperature, humidity and trace gases throughout the atmosphere – enabling forecasters to detect the earliest signs of severe weather, extend the lead times of weather warnings, improve forecasting, and help protect lives and property.

Phil Evans, Director-General of EUMETSAT, said: “MTG-S1 will provide entirely new types of data products that will support specialists across EUMETSAT member states in detecting signs of atmospheric instability even before clouds begin to form. Combined with data from the MTG imaging satellites, it will, for the first time, offer a space-based view of the full lifecycle of convective storms. This will provide tremendous support to national meteorological services in carrying out their vital work, helping to save lives, reduce disruption, and strengthen resilience.

“The effects of the climate crisis are not distant threats: they are already being felt across Europe – through more frequent storms, longer heatwaves, and shifting climate patterns. MTG-S1 will support more timely warnings, safer travel decisions, more effective emergency response, and support informed action.

“My sincere thanks go to everyone who made MTG-S1 possible – our teams at EUMETSAT, our member states, the European Union, the European Space Agency, national meteorological services, and all our industrial and academic partners. This successful launch is a testament to the strength of European cooperation. We now look forward to moving to the next phases and preparing the satellite for full operations.”

A forecasting revolution

MTG-S1 is the first geostationary meteorological sounder satellite to fly over Europe and carries two key missions: the Infrared Sounder and the European Union’s Copernicus Sentinel-4 Ultraviolet Visible Near-infrared spectrometer.

Applause broke out at EUMETSAT headquarters in Darmstadt, Germany, as staff, guests, and media watched a live stream of the satellite separating from its launcher and continuing its journey into orbit. Tension turned to celebration as confirmation arrived that the satellite had contacted ground control, deployed its solar panels, and was on course for geostationary orbit – some 36,000 km above the equator.

With power and communications established, MTG-S1 entered its Launch and Early Operations Phase, during which engineers are activating systems and guiding it to its geostationary orbital position. From this position, aligned with Earth’s rotation, MTG-S1 will maintain an uninterrupted view of Europe, Africa, and surrounding regions.

MTG-S1’s Infrared Sounder will scan nearly 2,000 thermal infrared wavelengths every 30 minutes to build vertical profiles of temperature, humidity, and trace gases. These data will be crucial for detecting fast-developing convective weather by revealing sudden shifts in instability, moisture, or wind – even before clouds begin to form.

Combined with imagery from MTG’s imager satellites, it will offer a continuous view of a storm’s full life cycle, from early instability through to lightning and dissipation. The observations made by MTG-S1 will also enhance very-short-range forecasts called nowcasts, daily forecasts, improve models linking weather, air quality, and climate, and support long-term climate monitoring.

The Copernicus Sentinel-4 mission is expected to provide hourly data on pollutants and aerosols – including from wildfires and volcanic eruptions – that will enable specialists to monitor emissions, enhance air quality forecasts, support public health and environmental policy. Copernicus is the Earth Observation component of the European Union Space Programme.

Simonetta Cheli, Director of Earth Observation Programmes at ESA, said: “These two groundbreaking missions are set to change the way we forecast both severe weather and the quality of air over Europe. It is thanks to the outstanding work our teams have done with EUMETSAT, the European Commission and dozens of European industry partners, that we are able to now look forward to more accurate and timely ways of predicting storm events and air pollution.”

Christoph Kautz, Director for Space Policy, Earth Observation and Satellite Navigation at the European Commission said: “I warmly congratulate everyone involved in the launch of MTG-S1 and Copernicus Sentinel-4, which will vastly enhance Europe’s ability to monitor the atmosphere from space. This achievement is a powerful example of how European cooperation can provide vital data in support of services such as the Copernicus Atmosphere Monitoring Service that protect public health, strengthen environmental monitoring, and improve lives across Europe.”

For further updates on MTG-S1, visit EUMETSAT’s launch hub, which features news, interviews, and insights into the satellite’s journey.

Find all relevant information, biographies of speakers, videos and testimonials on our dedicated press page.

For more information, see the EUMETSAT website.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250702002782/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye